Page last updated: 2024-08-25

clarithromycin and Cystic Fibrosis

clarithromycin has been researched along with Cystic Fibrosis in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (5.41)	18.2507
2000's	16 (43.24)	29.6817
2010's	17 (45.95)	24.3611
2020's	2 (5.41)	2.80

Authors

Authors	Studies
Almond, LM; Beringer, PM; Chung, PS; Hong, E; Rao, AP	1
Arghittu, M; Biffi, A; Cariani, L; Colombo, C; D'Accico, M; Daccò, V; Gambazza, S; Girelli, D; Pizzamiglio, G; Sottotetti, S; Teri, A; Tortoli, E; Trovato, A	1
DaCosta, A; Esther, CR; Giddings, O; Gilligan, P; Jordan, CL; Lin, FC	1
Adir, Y; Lavon, O; Schneer, S; Shteinberg, M	1
Aguilera-Correa, JJ; Esteban, J; García-Coca, M; Mahíllo-Fernández, I; Pérez-Jorge, C; Rodríguez-Sevilla, G; Romera-García, D	1
Bergamini, G; Boaretti, M; Boschi, F; Cremonini, E; Lleo, M; Melotti, P; Ortombina, A; Sandri, A; Sorio, C	1
Alhajlan, M; Alhariri, M; Omri, A	1
Amighi, K; Pilcer, G; Rosière, R; Sebti, T; Traina, K; Vanderbist, F	1
Amighi, K; De Bueger, V; Pilcer, G; Sebti, T; Traina, K; Traore, H; Vanderbist, F	1
Lands, LC; Stanojevic, S	1
Alffenaar, JW; Buchard, A; Dalbøge, CS; Dalhoff, K; Duno, M; Høiby, N; Jensen, AG; Johansen, HK; Jürgens, G; Nielsen, XC; Pressler, T; Uges, DR	1
Antoniadis, A; Arvanitidis, K; Bouros, D; Filidou, E; Fouka, E; Kolios, G; Kotsianidis, I; Lamprianidou, E; Miltiades, P; Paraskakis, E	1
Hofmann, T; Scheuch, G; Siekmeier, R	1
Cambau, E; Guglielmetti, L; Mougari, F; Raskine, L; Sermet-Gaudelus, I; Veziris, N	1
Devleeschouwer, MJ; El Manssouri, N; Macé, C; Traore, H; Tré-Hardy, M; Vanderbist, F	1
Devleeschouwer, MJ; El Manssouri, N; Traore, H; Tré-Hardy, M; Vanderbist, F; Vaneechoutte, M	1
Ali-Dinar, T; Colin, AA	1
Bai, N; Cai, Y; Chai, D; Liang, BB; Liu, Y; Wang, R	1
Brennan, S; Henke, MO; Robinson, P; Rubin, BK; Schechter, MS; Shinkai, M; Sly, PD; Smith, J; Winfield, K	1
Alihodžić, S; Bencetić Mihaljević, V; Bosnar, M; Bošnjak, B; Brajša, K; Culić, O; Eraković Haber, V; Glojnarić, I; Hrvačić, B; Jelić, D; Kapić, S; Koštrun, S; Kragol, G; Marušić Ištuk, Z; Padovan, J; Spaventi, R; Tavčar, B; Verbanac, D; Vujasinović, I	1
Dige-Petersen, H; Koch, C; Lanng, S; Main, KM; Müller, J; Sillesen, IB; Skov, M	1
Schöni, MH	1
Forslöw, U; Geborek, A; Heurlin, N; Hjelte, L; Petrini, B	1
Kapranov, NI; Kashirskaja, NJ; Kokarovtseva, SN; Pukhalskaya, D; Pukhalsky, AL; Shmarina, GV	1
De Schepper, J; De Schutter, I; De Wachter, E; Malfroot, A; Vanbesien, J	1
Barker, PM; Gillie, DJ; Rubin, BK; Schechter, MS	1
Catherinot, E; Gaillard, JL; Le Bourgeois, M; Sermet-Gaudelus, I	1
Rubin, BK; Shinkai, M	1
Petrini, B	1
Devleeschouwer, MJ; Traore, H; Tré-Hardy, M; Vanderbist, F	1
Downey, S; Inderlied, CB; Kaminsky, C; Ross, LA; Rowland, J; Woo, MS	1
Berning, SE; Gilljam, M; Larsson, LO; Peloquin, CA; Strandvik, B	1
Colin, AA	1
Boushey, HA; Grundland, H; Liu, JT; Ordoñez, CL; Stulbarg, M	1
Brown-Elliott, BA; Wallace, RJ	1
Gaylor, AS; Reilly, JC	1

Reviews

10 review(s) available for clarithromycin and Cystic Fibrosis

Article	Year
[LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES]. Harefuah, 2016, Volume: 155, Issue:9 Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Lung Diseases; Macrolides	2016
Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis. The Cochrane database of systematic reviews, 2013, Jun-13, Issue:6 Topics: Administration, Oral; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Cystic Fibrosis; Humans; Ibuprofen; Piroxicam; Randomized Controlled Trials as Topic; Sulfonamides	2013
Inhalation of macrolides: a novel approach to treatment of pulmonary infections. Advances in experimental medicine and biology, 2015, Volume: 839 Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Ketolides; Lung; Macrolides; Pulmonary Disease, Chronic Obstructive; Rats	2015
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. Expert review of anti-infective therapy, 2016, Volume: 14, Issue:12 Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Humans; Mycobacterium; Mycobacterium Infections; Prevalence; Respiratory Tract Infections; Treatment Outcome; Virulence	2016
Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:5 Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Humans; Lung; Macrolides; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Respiratory Function Tests; Treatment Outcome	2011
Macrolide antibiotic therapy in patients with cystic fibrosis. Swiss medical weekly, 2003, May-31, Volume: 133, Issue:21-22 Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Cystic Fibrosis; Erythromycin; Humans; Randomized Controlled Trials as Topic	2003
[Nontuberculous mycobacteria in cystic fibrosis]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12 Suppl 2 Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Child; Clarithromycin; Cystic Fibrosis; Drug Therapy, Combination; Ethambutol; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifampin	2005
Macrolides and airway inflammation in children. Paediatric respiratory reviews, 2005, Volume: 6, Issue:3 Topics: Anti-Bacterial Agents; Asthma; Azithromycin; Bronchitis; Child; Clarithromycin; Cystic Fibrosis; Drug Resistance; Humans; Inflammation; Macrolides; Respiratory Tract Diseases	2005
Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2006, Volume: 114, Issue:5 Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Respiratory Tract Infections; Skin; Soft Tissue Infections; Species Specificity; Surgical Wound Infection; Tigecycline; Tuberculosis, Cutaneous; Wounds and Injuries	2006
Therapy with macrolides in patients with cystic fibrosis. Pharmacotherapy, 2002, Volume: 22, Issue:2 Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Cystic Fibrosis; Erythromycin; Humans; Inflammation; Molecular Structure; Pseudomonas aeruginosa	2002

Trials

3 trial(s) available for clarithromycin and Cystic Fibrosis

Article	Year
[Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial]. The Japanese journal of antibiotics, 2013, Volume: 66 Suppl A Topics: Adolescent; Anti-Bacterial Agents; Clarithromycin; Cystic Fibrosis; Female; Humans; Male	2013
Clarithromycin therapy for patients with cystic fibrosis: a randomized controlled trial. Pediatric pulmonology, 2012, Volume: 47, Issue:6 Topics: Adolescent; Adult; Child; Child, Preschool; Clarithromycin; Cross-Over Studies; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Immunomodulation; Male; Protein Synthesis Inhibitors; Quality of Life; Treatment Outcome; Vital Capacity	2012
Effect of macrolides on in vivo ion transport across cystic fibrosis nasal epithelium. American journal of respiratory and critical care medicine, 2005, Apr-15, Volume: 171, Issue:8 Topics: Adolescent; Adult; Animals; Azithromycin; Child; Clarithromycin; Cross-Over Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Double-Blind Method; Humans; Ion Transport; Macrolides; Male; Membrane Potentials; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CFTR; Mice, Knockout; Nasal Mucosa	2005

Other Studies

24 other study(ies) available for clarithromycin and Cystic Fibrosis

Article	Year
Physiologically Based Pharmacokinetic Modeling To Guide Management of Drug Interactions between Elexacaftor-Tezacaftor-Ivacaftor and Antibiotics for the Treatment of Nontuberculous Mycobacteria. Antimicrobial agents and chemotherapy, 2022, 11-15, Volume: 66, Issue:11 Topics: Anti-Bacterial Agents; Benzodioxoles; Clarithromycin; Clofazimine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Nontuberculous Mycobacteria; Pyrrolidines; Rifabutin	2022
Molecular characterization of Mycobacterium abscessus subspecies isolated from patients attending an Italian Cystic Fibrosis Centre. The new microbiologica, 2020, Volume: 43, Issue:3 Topics: Anti-Bacterial Agents; Clarithromycin; Cystic Fibrosis; Drug Resistance, Bacterial; Humans; Italy; Macrolides; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Retrospective Studies; RNA, Ribosomal, 16S	2020
Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2017, Volume: 16, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Child; Clarithromycin; Cystic Fibrosis; Drug Monitoring; Female; Humans; Male; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Respiratory Function Tests; Respiratory Tract Infections; Retrospective Studies; Sputum; Treatment Outcome; United States	2017
Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model. International journal of medical microbiology : IJMM, 2018, Volume: 308, Issue:3 Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Cystic Fibrosis; Humans; In Vitro Techniques; Models, Biological; Mycobacterium abscessus; Nontuberculous Mycobacteria; Pseudomonas aeruginosa; Pseudomonas Infections	2018
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice. Virulence, 2018, Volume: 9, Issue:1 Topics: Animals; Bacterial Proteins; Clarithromycin; Cystic Fibrosis; Disease Models, Animal; Female; Humans; Interleukin-8; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors	2018
Efficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factors. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Anti-Bacterial Agents; Biofilms; Cell Line, Tumor; Clarithromycin; Cystic Fibrosis; Epithelial Cells; Humans; Liposomes; Lung; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Virulence Factors	2013
New co-spray-dried tobramycin nanoparticles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients. Journal of pharmaceutical sciences, 2013, Volume: 102, Issue:6 Topics: Administration, Inhalation; Anti-Bacterial Agents; Clarithromycin; Cystic Fibrosis; Desiccation; Drug Delivery Systems; Humans; Lung; Lung Diseases; Nanoparticles; Powders; Respiratory Tract Infections; Solubility; Tobramycin	2013
Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis. International journal of pharmaceutics, 2013, Jul-15, Volume: 451, Issue:1-2 Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Crystallization; Cystic Fibrosis; Drug Combinations; Drug Compounding; Drug Synergism; Dry Powder Inhalers; Lung; Lung Diseases; Microscopy, Electron, Scanning; Particle Size; Powders; Tissue Distribution; Tobramycin; X-Ray Diffraction	2013
Pharmacokinetic variability of clarithromycin and differences in CYP3A4 activity in patients with cystic fibrosis. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2014, Volume: 13, Issue:2 Topics: Adult; Anti-Bacterial Agents; Area Under Curve; Biotransformation; Breath Tests; Chromatography, Liquid; Clarithromycin; Cystic Fibrosis; Cytochrome P-450 CYP3A; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Genetic Association Studies; Humans; Male; Polymorphism, Single Nucleotide; Prospective Studies; Risk Assessment; Tandem Mass Spectrometry; Treatment Failure	2014
Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients. Lung, 2014, Volume: 192, Issue:6 Topics: Adult; Aged; Blood Gas Analysis; Breath Tests; Bronchiectasis; Bronchoalveolar Lavage Fluid; Clarithromycin; Cohort Studies; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Interleukin-17; Male; Middle Aged; Respiratory Function Tests; Risk Assessment; Sampling Studies; Severity of Illness Index; Th17 Cells; Treatment Outcome	2014
Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model. International journal of antimicrobial agents, 2009, Volume: 33, Issue:1 Topics: Anti-Bacterial Agents; Biofilms; Burkholderia cepacia; Clarithromycin; Cystic Fibrosis; Drug Combinations; Drug Synergism; Humans; Microbial Sensitivity Tests; Models, Biological; Pseudomonas aeruginosa; Staphylococcus aureus; Time Factors; Tobramycin	2009
Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa. International journal of antimicrobial agents, 2009, Volume: 34, Issue:4 Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Colony Count, Microbial; Cystic Fibrosis; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Genotype; Humans; Models, Biological; Phenotype; Pseudomonas aeruginosa; Sputum; Time Factors; Tobramycin; Treatment Outcome	2009
Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up. Pediatric pulmonology, 2010, Volume: 45, Issue:6 Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Cystic Fibrosis; Drug Therapy, Combination; Female; Forced Expiratory Volume; Gram-Negative Bacterial Infections; Humans; Mycobacterium; Mycobacterium Infections; Nebulizers and Vaporizers; Pseudomonas aeruginosa; Pseudomonas Infections; Stenotrophomonas maltophilia	2010
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity. Journal of medicinal chemistry, 2012, Jul-12, Volume: 55, Issue:13 Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Bronchiolitis; Bronchoalveolar Lavage Fluid; Cell Line; Clarithromycin; Cystic Fibrosis; Drug Interactions; Drug Resistance, Bacterial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Interleukin-6; Lipopolysaccharides; Lung; Macrolides; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moraxella catarrhalis; Neutrophils; Rats; Rats, Sprague-Dawley; Streptococcus	2012
Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient. Acta paediatrica (Oslo, Norway : 1992), 2002, Volume: 91, Issue:9 Topics: Adult; Anti-Inflammatory Agents; Aspergillosis, Allergic Bronchopulmonary; Budesonide; Clarithromycin; Cushing Syndrome; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Follow-Up Studies; Humans; Itraconazole; Risk Assessment	2002
Early chemotherapy for non-tuberculous mycobacterial infections in patients with cystic fibrosis. Acta paediatrica (Oslo, Norway : 1992), 2003, Volume: 92, Issue:8 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Child; Clarithromycin; Cohort Studies; Cystic Fibrosis; Ethambutol; Female; Humans; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Retrospective Studies; Rifampin; Streptomycin	2003
Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease. Mediators of inflammation, 2004, Volume: 13, Issue:2 Topics: Adolescent; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Child; Clarithromycin; Cystic Fibrosis; Cytokines; Female; Humans; Immunologic Factors; Inflammation; Lymphocytes; Male; Respiratory Function Tests; Sputum	2004
Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2003, Volume: 2, Issue:2 Topics: Administration, Inhalation; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bronchodilator Agents; Budesonide; Clarithromycin; Cushing Syndrome; Cystic Fibrosis; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Fatal Outcome; Female; Humans; Iatrogenic Disease; Infant, Newborn; Itraconazole; Lung Diseases; Male; Mycobacterium Infections, Nontuberculous	2003
In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. International journal of antimicrobial agents, 2008, Volume: 31, Issue:4 Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Cystic Fibrosis; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Polymyxin B; Pseudomonas aeruginosa; Tobramycin	2008
Pediatric transplant grand rounds. A case presentation: skin lesions in a post-lung transplant patient. Pediatric transplantation, 1997, Volume: 1, Issue:2 Topics: Adolescent; Anti-Bacterial Agents; Clarithromycin; Cystic Fibrosis; Female; Humans; Lung Transplantation; Mycobacterium Infections, Nontuberculous; Postoperative Complications	1997
Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease. The European respiratory journal, 1999, Volume: 14, Issue:2 Topics: Adolescent; Adult; Antitubercular Agents; Biological Availability; Clarithromycin; Cystic Fibrosis; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Mycobacterium avium-intracellulare Infection; Pregnancy; Rifampin; Tuberculosis, Pulmonary	1999
Eradication of mycobacterium abscessus in a chronically infected patient with cystic fibrosis. Pediatric pulmonology, 2000, Volume: 30, Issue:3 Topics: Administration, Inhalation; Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Lung Abscess; Mycobacterium; Mycobacterium Infections; Recurrence	2000
Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study. Pediatric pulmonology, 2001, Volume: 32, Issue:1 Topics: Adult; Airway Obstruction; Anti-Bacterial Agents; Biomarkers; Clarithromycin; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Inflammation; Interleukin-8; Leukocyte Elastase; Male; Neutrophils; Peroxidase; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Respiratory Function Tests; Single-Blind Method; Sputum; Treatment Outcome; Tumor Necrosis Factor-alpha	2001
Clarithromycin resistance to Mycobacterium abscessus. Journal of clinical microbiology, 2001, Volume: 39, Issue:7 Topics: Anti-Bacterial Agents; Clarithromycin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Mycobacterium; Mycobacterium Infections	2001